• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用B族链球菌表面蛋白Sip和ScpB进行鼻内免疫可诱导小鼠产生特异性黏膜和全身免疫反应。

Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice.

作者信息

Xue Guanhua, Yu Lihua, Li Shentao, Shen Xuzhuang

机构信息

Beijing Children's Hospital, Capital Medical University, Beijing, China.

出版信息

FEMS Immunol Med Microbiol. 2010 Mar;58(2):202-10. doi: 10.1111/j.1574-695X.2009.00623.x. Epub 2009 Oct 12.

DOI:10.1111/j.1574-695X.2009.00623.x
PMID:19912341
Abstract

Sip and ScpB are highly conserved among strains of Group B Streptococcus (GBS). Thus, the two proteins are attractive antigens for inclusion in a vaccine against GBS. In this study, we constructed and expressed the two proteins, and investigated their specific mucosal immune responses against GBS induced by intranasal immunization with cholera toxin (CT) and CpG-oligodeoxynucleotides (CpG-ODNs). Intranasal immunization with different doses of recombinant Sip and ScpB all elicited specific antibodies in serum and vagina of mice. A combination of rSip and rScpB with either CT or CpG-ODN elicited specific antibodies in serum and vaginal samples. Th1 responses were enhanced by CpG and CT. Sera from the mice group intranasally immunized with rSip+CT, rScpB+CT, rSip+rScpB+CT, and rSip+rScpB+CpG also showed bactericidal activity compared with the serum of the control group. The current findings suggest that rSip and rScpB would be useful antigens as a vaccine component to induce protective immune responses against GBS, and CpG-ODN could be used as an effective mucosal adjuvant in inducing a good mucosal immune response. The use of an intranasal vaccine composed of different surface protein antigens is an attractive strategy for the development of a vaccine against GBS.

摘要

Sip和ScpB在B族链球菌(GBS)菌株中高度保守。因此,这两种蛋白质是用于GBS疫苗的有吸引力的抗原。在本研究中,我们构建并表达了这两种蛋白质,并研究了用霍乱毒素(CT)和CpG-寡脱氧核苷酸(CpG-ODN)经鼻免疫诱导的针对GBS的特异性黏膜免疫反应。用不同剂量的重组Sip和ScpB经鼻免疫均在小鼠血清和阴道中诱导产生了特异性抗体。rSip和rScpB与CT或CpG-ODN的组合在血清和阴道样本中诱导产生了特异性抗体。CpG和CT增强了Th1反应。与对照组血清相比,经鼻免疫rSip+CT、rScpB+CT、rSip+rScpB+CT和rSip+rScpB+CpG的小鼠组血清也显示出杀菌活性。目前的研究结果表明,rSip和rScpB作为疫苗成分可诱导针对GBS的保护性免疫反应,CpG-ODN可作为诱导良好黏膜免疫反应的有效黏膜佐剂。使用由不同表面蛋白抗原组成的鼻内疫苗是开发GBS疫苗的一种有吸引力的策略。

相似文献

1
Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice.用B族链球菌表面蛋白Sip和ScpB进行鼻内免疫可诱导小鼠产生特异性黏膜和全身免疫反应。
FEMS Immunol Med Microbiol. 2010 Mar;58(2):202-10. doi: 10.1111/j.1574-695X.2009.00623.x. Epub 2009 Oct 12.
2
A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.流感嗜血杆菌的重组P4蛋白在鼻内免疫后可诱导对小鼠鼻咽部定植具有生物活性的特异性免疫反应。
Vaccine. 2005 Jan 26;23(10):1294-300. doi: 10.1016/j.vaccine.2004.08.042.
3
Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.用CpG寡脱氧核苷酸进行鼻腔接种可诱导对鼻咽部不可分型流感嗜血杆菌的保护性免疫。
Laryngoscope. 2006 Mar;116(3):407-12. doi: 10.1097/01.mlg.0000199740.04730.d4.
4
Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).针对HIV-1的黏膜免疫:用HIV-1 C4/V3肽T1SP10 MN(A)经鼻免疫后的全身和阴道抗体反应。
J Immunol. 1996 Jul 1;157(1):462-72.
5
Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.用于鼻内免疫的实验性B族链球菌III型多糖-霍乱毒素B亚单位结合疫苗的制备及临床前评价
Vaccine. 2000 Nov 22;19(7-8):850-61. doi: 10.1016/s0264-410x(00)00226-7.
6
Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.鼻内给药是一种有效的黏膜疫苗递送途径,用于针对A组链球菌M蛋白的自佐剂脂质核心肽。
J Infect Dis. 2006 Aug 1;194(3):316-24. doi: 10.1086/505580. Epub 2006 Jun 30.
7
Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.舌下给予天然或变性蛋白过敏原与佐剂CpG寡脱氧核苷酸或霍乱毒素对小鼠全身Th2免疫反应和黏膜免疫的影响。
Ann Allergy Asthma Immunol. 2007 Nov;99(5):443-52. doi: 10.1016/S1081-1206(10)60570-4.
8
The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.与霍乱毒素无毒B亚基相连的CpG寡脱氧核苷酸对小鼠抗幽门螺杆菌免疫诱导的佐剂作用。
Scand J Immunol. 2008 May;67(5):431-40. doi: 10.1111/j.1365-3083.2008.02085.x. Epub 2008 Feb 21.
9
CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.CpG DNA通过对小鼠鼻内给药,是针对乙肝表面抗原的全身和黏膜免疫反应的有效增强剂。
J Immunol. 1998 Nov 1;161(9):4463-6.
10
Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.既往免疫对III型B族链球菌荚膜多糖-霍乱毒素B亚单位结合物鼻内免疫的全身和黏膜免疫反应的影响。
Vaccine. 2001 May 14;19(25-26):3360-8. doi: 10.1016/s0264-410x(00)00532-6.

引用本文的文献

1
A CRISPRi library screen in group B identifies surface immunogenic protein (Sip) as a mediator of multiple host interactions.在B组中进行的CRISPR干扰文库筛选确定表面免疫原性蛋白(Sip)是多种宿主相互作用的介质。
Infect Immun. 2025 Apr 8;93(4):e0057324. doi: 10.1128/iai.00573-24. Epub 2025 Mar 21.
2
Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific Immunity.多层佐剂流感蛋白纳米颗粒改善鼻内给药及抗原特异性免疫。
ACS Nano. 2025 Feb 25;19(7):7005-7025. doi: 10.1021/acsnano.4c14735. Epub 2025 Feb 15.
3
A CRISPRi Library Screen in Group B Identifies Surface Immunogenic Protein (Sip) as a Mediator of Multiple Host Interactions.
B组中的CRISPRi文库筛选确定表面免疫原性蛋白(Sip)是多种宿主相互作用的介质。
bioRxiv. 2024 Dec 7:2024.12.06.627252. doi: 10.1101/2024.12.06.627252.
4
Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines.使用表面免疫原性蛋白作为载体蛋白,针对B族链球菌聚糖结合疫苗候选物引发针对多种血清型的保护性抗体。
Vaccines (Basel). 2024 May 24;12(6):573. doi: 10.3390/vaccines12060573.
5
Characterization and virulence of deficient in of the two-component system.双组分系统中缺乏某成分的特性及毒力
Front Microbiol. 2023 Apr 17;14:1121621. doi: 10.3389/fmicb.2023.1121621. eCollection 2023.
6
Immunogenic Proteins of Group B Streptococcus-Potential Antigens in Immunodiagnostic Assay for GBS Detection.B族链球菌的免疫原性蛋白——用于GBS检测的免疫诊断测定中的潜在抗原
Pathogens. 2021 Dec 31;11(1):43. doi: 10.3390/pathogens11010043.
7
The Role of Streptococcal Cell-Envelope Proteases in Bacterial Evasion of the Innate Immune System.链球菌细胞包膜蛋白酶在细菌逃避固有免疫系统中的作用。
J Innate Immun. 2022;14(2):69-88. doi: 10.1159/000516956. Epub 2021 Oct 14.
8
Research Advances on Tilapia Streptococcosis.罗非鱼链球菌病的研究进展
Pathogens. 2021 May 6;10(5):558. doi: 10.3390/pathogens10050558.
9
Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples.临床样本中 B 群链球菌毒力因子与耐药基因分析。
BMC Infect Dis. 2021 Jan 28;21(1):125. doi: 10.1186/s12879-021-05820-6.
10
The Impact of Circulating Antibody on Group B Intestinal Colonization and Invasive Disease.循环抗体对 B 组肠定植和侵袭性疾病的影响。
Infect Immun. 2020 Dec 15;89(1). doi: 10.1128/IAI.00348-20.